Drug Trial Radar · NCT03682471
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
Last checked: Nov 19, 2026Latest source record: Sep 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
201
Actual
Start
Feb 14, 2012
Primary completion
Dec 13, 2013
Study completion Dec 13, 2013
Sponsor
- Lead sponsor
- AllerganAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Sep 24, 2018
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this non-treatment, placebo-controlled, observational, 24-month follow-up study was to evaluate the long-term efficacy and safety of subcutaneous (SC) injections of deoxycholic acid (ATX-101) in the submental area. No treatment was administered in this study. Participants who previously received deoxycholic acid injections in studies ATX-101-10-16 \[NCT01305577\] or ATX-101-10-17 \[NCT01294644\] were enrolled in this non-treatment observational follow-up study to further evaluate safety and efficacy.
Conditions
- Subcutaneous Fat
Interventions
Deoxycholic acid InjectionDrug
Solution for subcutaneous injection.
PlaceboDrug
Placebo, 10 mM sodium phosphate, 0.9% \[w/v\] sodium chloride in water for subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Maintaining Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) 1-Grade Response During the 24 Months of Follow up, i.e. % of Participants who were CR-SMFRS 1-Grade Responders at both LTFU Baseline and at 24-Month VisitTime frame: LTFU Baseline (Month 0) to Month 24
- Percentage of Participants with Maintenance of Response as Assessed by the Subject Satisfaction Rating Scale (SSRS) During the 24 Months of Follow up, i.e. % of Participants who were SSRS Responders at both LTFU Baseline and at 24-Month VisitTime frame: LTFU Baseline (Month 0) to Month 24
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Licca Clinical Research Institute
Augsburg, Germany
Campus Charité Mitte, Klinik für Dermatologie, Venerologie und Allergologie
Berlin, Germany
Ruhruniversität Bochum - St. Josef Hospital
Bochum, Germany
Klinikum Darmstadt
Darmstadt, Germany
Krankenhaus Dresden- Friedrichstadt Klinik für Dermatologie und Allergologie
Dresden, Germany
Dr. Beatrice Gerlach
Dresden, Germany
Klinikum der Johann-Wolfgang Goethe-Universität - Klinik für Dermatologie, Venerologie und Allergologie
Frankfurt, Germany
Hautarztpraxis Cutanis
Freiburg im Breisgau, Germany
Universitätsklinik Schleswig Holstein, Campus Luebeck, Klinik f. Dermatologie
Lübeck, Germany
Praxis Dr. Walker and Dr. Biwer
Ludwigshafen, Germany
Gemeinschaftsprax is für Dermatologie
Mahlow, Germany
Ludwig- Maximilians- Universität München, Klinik für Dermatologie und Allergologie
München, Germany
Germania Campus PraxisKlinik
Münster, Germany
Praxis Dr. Graefe
Northeim, Germany
Haut- und Laserzentrum Potsdam
Potsdam, Germany
Klinik für Dermatologie und Allergologie Klinikum Vest GmbH Recklinghausen
Recklinghausen, Germany
Hautzentrum am Starnberger See GmbH
Starnberg, Germany
Dermatologische Privatpraxis
Wuppertal, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.